Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder [NA]

View source ↗

Summary

The NIDA-sponsored clinical trial studying the effects of neurostimulation on risky and ambiguous decision-making in people with opioid use disorder and healthy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid Use Disorder, Healthy Volunteers | NA | Status: SUSPENDED